WOODCLIFF LAKE, N.J. (AP) _ Eagle Pharmaceuticals Inc. (EGRX) on Monday reported a second-quarter loss of $256,000, after reporting a profit in the same period a year earlier.
On a per-share basis, the Woodcliff Lake, New Jersey-based company said it had a loss of 2 cents. Earnings, adjusted for stock option expense and non-recurring costs, came to 57 cents per share.
The specialty pharmaceutical company posted revenue of $41.9 million in the period.
Eagle Pharmaceuticals shares have decreased 22% since the beginning of the year. The stock has decreased 17% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EGRX at https://www.zacks.com/ap/EGRX
